2019
DOI: 10.1016/j.mmcr.2018.09.007
|View full text |Cite|
|
Sign up to set email alerts
|

Posaconazole and isavuconazole induced hypomagnesaemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“… 36 , 37 , 42 , 43 With regard to other antifungal agents, posaconazole and isavuconazole have also been associated with hypomagnesemia. 44 The exact mechanism has not been elucidated.…”
Section: Drugs Associated With Hypomagnesemiamentioning
confidence: 99%
See 1 more Smart Citation
“… 36 , 37 , 42 , 43 With regard to other antifungal agents, posaconazole and isavuconazole have also been associated with hypomagnesemia. 44 The exact mechanism has not been elucidated.…”
Section: Drugs Associated With Hypomagnesemiamentioning
confidence: 99%
“…Furthermore, both classes of drugs can also cause other renal tubular disorders, including proximal and distal renal tubular acidosis and nephrogenic diabetes insipidus 36,37,42,43 . With regard to other antifungal agents, posaconazole and isavuconazole have also been associated with hypomagnesemia 44 . The exact mechanism has not been elucidated.…”
Section: Drugs Associated With Hypomagnesemiamentioning
confidence: 99%
“…After exclusion of reports published in non-English language or in which clinical and therapeutic data were not available for the purpose of the present review, a total of 41 cases have been included. Clinical and demographic characteristics, details of the antifungal treatment, outcome and adverse effects reported on these patients are summarized in Table 2 [ 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 ]. Thirty-three out of 42 (78.5%) patients were male and the mean age was 52 years (range 20–79).…”
Section: Isavuconazole In Non-hematological Patientsmentioning
confidence: 99%